The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies
出版年份 2014 全文链接
标题
The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies
作者
关键词
-
出版物
JOURNAL OF INTERNAL MEDICINE
Volume 276, Issue 1, Pages 61-70
出版商
Wiley
发表日期
2014-03-18
DOI
10.1111/joim.12208
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
- (2014) Julien Ablain et al. NATURE MEDICINE
- OBFC2A/RARA: a novel fusion gene in variant acute promyelocytic leukemia
- (2013) D. Won et al. BLOOD
- SUMOylation of p53 mediates interferon activities
- (2013) Laura Marcos-Villar et al. CELL CYCLE
- Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha
- (2013) Rabab M. El Eit et al. INTERNATIONAL JOURNAL OF CANCER
- Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies
- (2013) Julien Ablain et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Corepressor CTBP2 Is a Coactivator of Retinoic Acid Receptor/Retinoid X Receptor in Retinoic Acid Signaling
- (2013) Prashanth Kumar Bajpe et al. MOLECULAR AND CELLULAR BIOLOGY
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudin induces p53 signaling and apoptosis in HTLV-1-infected cells
- (2013) Shuichi Kinpara et al. Retrovirology
- Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups
- (2013) L Riva et al. Blood Cancer Journal
- Acute promyelocytic leukemia, arsenic, and PML bodies
- (2012) Hugues de Thé et al. JOURNAL OF CELL BIOLOGY
- Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL
- (2012) M Leiva et al. LEUKEMIA
- Pml represses tumour progression through inhibition of mTOR
- (2011) Rosa Bernardi et al. EMBO Molecular Medicine
- Regulation of E2Fs and senescence by PML nuclear bodies
- (2011) M. Vernier et al. GENES & DEVELOPMENT
- Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression
- (2011) Lukas D. Wartman et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
- (2011) Ardeshir Ghavamzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Curing APL through PML/RARA degradation by As2O3
- (2011) Valerie Lallemand-Breitenbach et al. TRENDS IN MOLECULAR MEDICINE
- BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
- (2010) Y. Yamamoto et al. BLOOD
- Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
- (2010) P. Isakson et al. BLOOD
- PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
- (2010) Joost H.A. Martens et al. CANCER CELL
- Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
- (2010) Vikram Mathews et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
- (2010) Hiba El Hajj et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: A systematic review
- (2010) Amer Beitinjaneh et al. LEUKEMIA RESEARCH
- Dual Role of p53 in Innate Antiviral Immunity
- (2010) Carmen Rivas et al. Viruses-Basel
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
- (2009) G. Kchour et al. BLOOD
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia
- (2008) T. Kondo et al. HAEMATOLOGICA
- MBD3, a Component of the NuRD Complex, Facilitates Chromatin Alteration and Deposition of Epigenetic Marks
- (2008) L. Morey et al. MOLECULAR AND CELLULAR BIOLOGY
- RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
- (2008) Michael H. Tatham et al. NATURE CELL BIOLOGY
- Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
- (2008) Valérie Lallemand-Breitenbach et al. NATURE CELL BIOLOGY
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now